TerrAscend Commences Cultivation of Medical Cannabis

TORONTO, Aug. 29, 2017 (GLOBE NEWSWIRE) — TerrAscend Corp. (CSE:TER) (“TerrAscend” or the “Company”), is pleased to announce that its wholly-owned subsidiary, Solace Health Inc. (“Solace Health”), has commenced cultivation activities at its headquarters in Mississauga, Ontario. The experienced team at Solace Health will begin cultivation by planting rooted starting materials, with an anticipated flowering cycle of approximately eight weeks. Solace Health will initially cultivate a variety of cannabis strains sought by Canadian patients, including offerings with varying THC and CBD concentrations and genetic subtypes.

We’re excited to begin our cultivation efforts and provide Canada’s medical cannabis community with a truly high quality, premium product. Planting our first crop is monumental for TerrAscend and Solace Health as it enables us to diligently move forward and obtain further licenses, including a sales license, through Health Canada.

TerrAscend’s President & Chief Executive Officer, Basem Hanna

Solace Health’s cultivation and facility teams have built a state of the art, indoor hydroponic growing environment that will enable it to produce high quality, pesticide-free medical cannabis for Canadian patients under the Access to Cannabis for Medical Purposes Regulations. To achieve their strict quality standards, the cultivation team has built a modular, purpose-built facility that provides comprehensive environmental controls and pest management systems.

About TerrAscend

TerrAscend is a vertically-integrated Canadian cannabis company that strives to create and deliver quality products and services that meet the evolving needs of the cannabis market. The Company provides support to patients through its wholly-owned subsidiaries, Solace Health Inc., a licensed producer of medical cannabis under the Access to Cannabis for Medical Purposes Regulations, Terra Health Network Inc. (“Terra Health”), a clinical support program and education platform led by health care professionals, and Solace Rx Inc. (“SolaceRx”), a drug preparation premises for non-cannabis formulations. Please visit www.TerrAscend.com for more information about the Company.

Original press release: https://globenewswire.com/news-release/2017/08/29/1101750/0/en/TerrAscend-Commences-Cultivation-of-Medical-Cannabis.html

Published by NCV Newswire
NCV Newswire
The NCV Newswire by New Cannabis Ventures aims to curate high quality content and information about leading cannabis companies to help our readers filter out the noise and to stay on top of the most important cannabis business news. The NCV Newswire is hand-curated by an editor and not automated in anyway. Have a confidential news tip? Get in touch.

Get Our Sunday Newsletter